Skip to main content

5 Result(s)

within J. Kattan Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Comparative genomic characterization of melanoma of known and unknown primary

    This study aims to genomically characterize melanoma of unknown primary (MUP) in comparison to melanomas of cutaneous primary (MCP).

    E. Rassy, S. Boussios, A. Chebly, C. Farra… in Clinical and Translational Oncology (2021)

  2. No Access

    Article

    Overview on the role of preoperative therapy in the management of kidney cancer

    The advent of molecular therapy through targeted kinase inhibitors (TKI) has revolutionized the management of renal cell carcinoma. Although surgical resection remains the cornerstone of any therapeutic plan, ...

    T. Assi, E. El Rassy, F. Farhat, J. Kattan in Clinical and Translational Oncology (2020)

  3. No Access

    Article

    Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder

    Metastatic urothelial carcinoma of the bladder is a rarely curable disease. Patients receive systemic therapy with limited response rates and survival benefits. The rescue regimens of these patients who have f...

    E. El Rassy, T. Assi, Z. Bakouny, N. Pavlidis… in Clinical and Translational Oncology (2019)

  4. No Access

    Article

    Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer

    This prospective phase II trial aims to evaluate the sequential FOLFOX-6 and gemcitabine followed by adapted maintenance for advanced pancreatic cancer. Treatment included FOLFOX-6 for 4 cycles, followed seque...

    M. Ghosn, A. Saroufim, J. Kattan, G. Chahine, F. Nasr, F. Farhat in Medical Oncology (2012)

  5. No Access

    Article

    Phase II trial of pirarubicin in the treatment of advanced bladder cancer

    Doxorubicin is one of the standard drugs in the chemotherapy of advanced urothelial tumors. Pirarubicin, a new anthracycline, turned out to be equally active and less toxic than its parent compound in preclini...

    M. Mahjoubi, J. Kattan, M. Ghosn, J. -P. Droz, I. Philippot… in Investigational New Drugs (1992)